Duloxetine in the Treatment of Women with Urinary Incontinence: A Systematic Review and Meta-analysis of Efficacy Data from Randomized Controlled Clinical Trials
Duloxetine is the only available agent for the medical treatment of stress urinary incontinence (SUI). In this systematic review, we analyzed the efficacy and safety of duloxetine treatment in women with SUI and stress-predominant mixed urinary incontinence (SPMUI). We searched the literature using...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2023-03-01
|
| Series: | Journal of Urological Surgery |
| Subjects: | |
| Online Access: |
http://jurolsurgery.org/archives/archive-detail/article-preview/duloxetine-in-the-treatment-of-women-with-urinary-/58869
|
| _version_ | 1797884330733731840 |
|---|---|
| author | Naşide Mangır Murat Uçar Ömer Gülpınar Cüneyd Özkürkçügil Oktay Demirkesen Tufan Tarcan |
| author_facet | Naşide Mangır Murat Uçar Ömer Gülpınar Cüneyd Özkürkçügil Oktay Demirkesen Tufan Tarcan |
| author_sort | Naşide Mangır |
| collection | DOAJ |
| description | Duloxetine is the only available agent for the medical treatment of stress urinary incontinence (SUI). In this systematic review, we analyzed the efficacy and safety of duloxetine treatment in women with SUI and stress-predominant mixed urinary incontinence (SPMUI). We searched the literature using OVID MEDLINE, Embase and ULAKBIM (Turkish database) databases for placebo-controlled studies on the use of duloxetine in women with SUI or SPMUI. Data on change in incontinence episode frequency (IEF), decrease in the number of continence pads used, increase in voiding interval (minute) and discontinuation rates due to adverse effects and lack of efficacy (%) were extracted. A total of 12 randomized controlled trials were included. Duloxetine treatment results in an 18% decrease in IEF and 16% decrease in the number of incontinence pads used compared to pre-treatment status. It also increases the time interval between the voids by 18 min. Duloxetine treatment was associated with higher treatment discontinuation rates compared with placebo. The reason for discontinuation was related to the side effects of the treatment rather than lack of efficacy. Duloxetine can be an effective treatment option in women with UI based on high-level evidence supporting its efficacy. Further studies with larger patient populations and longer durations of follow-up are required to assess its safety profile. |
| first_indexed | 2024-04-10T04:04:49Z |
| format | Article |
| id | doaj.art-469efe6aa61a484181841f311b6da5ab |
| institution | Directory Open Access Journal |
| issn | 2148-9580 |
| language | English |
| last_indexed | 2024-04-10T04:04:49Z |
| publishDate | 2023-03-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Journal of Urological Surgery |
| spelling | doaj.art-469efe6aa61a484181841f311b6da5ab2023-03-13T06:27:27ZengGalenos YayineviJournal of Urological Surgery2148-95802023-03-011011810.4274/jus.galenos.2022.2022.002713049054Duloxetine in the Treatment of Women with Urinary Incontinence: A Systematic Review and Meta-analysis of Efficacy Data from Randomized Controlled Clinical TrialsNaşide Mangır0Murat Uçar1Ömer Gülpınar2Cüneyd Özkürkçügil3Oktay Demirkesen4Tufan Tarcan5 Hacettepe University Faculty of Medicine, Department of Urology, Ankara, Turkiye Alaaddin Keykubat University Faculty of Medicine, Department of Urology, Antalya, Turkiye Ankara University Faculty of Medicine, Department of Urology, Ankara, Turkiye Kocaeli University Faculty of Medicine, Department of Urology, Kocaeli, Turkiye Forte Urology Clinic, İstanbul, Turkiye Marmara University Faculty of Medicine, Department of Urology, Koç University Faculty of Medicine, Department of Urology, İstanbul, Turkiye Duloxetine is the only available agent for the medical treatment of stress urinary incontinence (SUI). In this systematic review, we analyzed the efficacy and safety of duloxetine treatment in women with SUI and stress-predominant mixed urinary incontinence (SPMUI). We searched the literature using OVID MEDLINE, Embase and ULAKBIM (Turkish database) databases for placebo-controlled studies on the use of duloxetine in women with SUI or SPMUI. Data on change in incontinence episode frequency (IEF), decrease in the number of continence pads used, increase in voiding interval (minute) and discontinuation rates due to adverse effects and lack of efficacy (%) were extracted. A total of 12 randomized controlled trials were included. Duloxetine treatment results in an 18% decrease in IEF and 16% decrease in the number of incontinence pads used compared to pre-treatment status. It also increases the time interval between the voids by 18 min. Duloxetine treatment was associated with higher treatment discontinuation rates compared with placebo. The reason for discontinuation was related to the side effects of the treatment rather than lack of efficacy. Duloxetine can be an effective treatment option in women with UI based on high-level evidence supporting its efficacy. Further studies with larger patient populations and longer durations of follow-up are required to assess its safety profile. http://jurolsurgery.org/archives/archive-detail/article-preview/duloxetine-in-the-treatment-of-women-with-urinary-/58869 urinary incontinencestressurinary incontinencemixedduloxetine hydrochloridesystematic review |
| spellingShingle | Naşide Mangır Murat Uçar Ömer Gülpınar Cüneyd Özkürkçügil Oktay Demirkesen Tufan Tarcan Duloxetine in the Treatment of Women with Urinary Incontinence: A Systematic Review and Meta-analysis of Efficacy Data from Randomized Controlled Clinical Trials Journal of Urological Surgery urinary incontinence stress urinary incontinence mixed duloxetine hydrochloride systematic review |
| title | Duloxetine in the Treatment of Women with Urinary Incontinence: A Systematic Review and Meta-analysis of Efficacy Data from Randomized Controlled Clinical Trials |
| title_full | Duloxetine in the Treatment of Women with Urinary Incontinence: A Systematic Review and Meta-analysis of Efficacy Data from Randomized Controlled Clinical Trials |
| title_fullStr | Duloxetine in the Treatment of Women with Urinary Incontinence: A Systematic Review and Meta-analysis of Efficacy Data from Randomized Controlled Clinical Trials |
| title_full_unstemmed | Duloxetine in the Treatment of Women with Urinary Incontinence: A Systematic Review and Meta-analysis of Efficacy Data from Randomized Controlled Clinical Trials |
| title_short | Duloxetine in the Treatment of Women with Urinary Incontinence: A Systematic Review and Meta-analysis of Efficacy Data from Randomized Controlled Clinical Trials |
| title_sort | duloxetine in the treatment of women with urinary incontinence a systematic review and meta analysis of efficacy data from randomized controlled clinical trials |
| topic | urinary incontinence stress urinary incontinence mixed duloxetine hydrochloride systematic review |
| url |
http://jurolsurgery.org/archives/archive-detail/article-preview/duloxetine-in-the-treatment-of-women-with-urinary-/58869
|
| work_keys_str_mv | AT nasidemangır duloxetineinthetreatmentofwomenwithurinaryincontinenceasystematicreviewandmetaanalysisofefficacydatafromrandomizedcontrolledclinicaltrials AT muratucar duloxetineinthetreatmentofwomenwithurinaryincontinenceasystematicreviewandmetaanalysisofefficacydatafromrandomizedcontrolledclinicaltrials AT omergulpınar duloxetineinthetreatmentofwomenwithurinaryincontinenceasystematicreviewandmetaanalysisofefficacydatafromrandomizedcontrolledclinicaltrials AT cuneydozkurkcugil duloxetineinthetreatmentofwomenwithurinaryincontinenceasystematicreviewandmetaanalysisofefficacydatafromrandomizedcontrolledclinicaltrials AT oktaydemirkesen duloxetineinthetreatmentofwomenwithurinaryincontinenceasystematicreviewandmetaanalysisofefficacydatafromrandomizedcontrolledclinicaltrials AT tufantarcan duloxetineinthetreatmentofwomenwithurinaryincontinenceasystematicreviewandmetaanalysisofefficacydatafromrandomizedcontrolledclinicaltrials |